GlaxoSmithKline PLC (GSK)
22 Aug 2014
|Market Cap (Mil.):||$114,925.20|
|Shares Outstanding (Mil.):||2,424.76|
Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Derek Francis in Bangalore)
SHANGHAI - British corporate investigator Peter Humphrey and his American wife Yu Yingzeng do not plan to appeal a Chinese court's decision to sentence them to prison, a lawyer told Reuters on Friday.
SHANGHAI, Aug 15 - British corporate investigator Peter Humphrey and his American wife Yu Yingzeng do not plan to appeal a Chinese court's decision to sentence them to prison, a lawyer told Reuters on Friday.
LONDON - GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country.
* Drugmaker working on experimental vaccine with U.S. NIAID
(Repeating story first sent on Aug 9 to additional subscribers)
NEW YORK/WASHINGTON - All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.
NEW YORK/WASHINGTON, Aug 9 - All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.
SHANGHAI - China sentenced a British corporate investigator to 2-1/2 years in prison on Friday for illegally obtaining private records of Chinese citizens and selling the information on to clients including drugmaker GlaxoSmithKline Plc. | Video
* Unclear whether wife will also be forced to leave China
|Takeda Pharmaceutical Co Ltd (4502.T)||¥4,722||+2.50|
|The Procter & Gamble Company (PG.N)||$83.39||+0.11|
|Johnson & Johnson (JNJ.N)||$103.10||-0.39|
|Pfizer Inc. (PFE.N)||$28.92||+0.10|
|Novartis AG (NOVN.VX)||CHF81.35||+0.25|
|Unilever N.V. (UNc.AS)||€31.03||-0.17|
|Unilever N.V. (UNIA.AS)||€31.15||-0.11|
|Unilever N.V. (UN_pa.AS)||--||--|
|Unilever N.V. (UN_p.AS)||€77.00||0.00|
|Unilever N.V. (UN_pb.AS)||--||--|
Earnings vs. Estimates
Analyst Research Reports
Provider: Pechala's Reports
GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Ford Investor Services, Inc.
"The Economy Matters" Report for GSK: the economy's impact on GSK's price and risk, featuring the powerful Economic Climate Rating
Provider: MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.